Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Microsoft Among 14 Dividend Growth Companies To Annual Dividend Increases In September

30 August 2026

Fidelity Blue Chip Growth ETF Q2 2026 Commentary (FBCG)

30 August 2026

Wasatch International Select Fund Q2 2026 Commentary (WAISX)

30 August 2026

Janus Henderson Global Adaptive Capital Allocation Managed Account Q2 2026 Commentary

30 August 2026

Standard Nuclear: The Business Is Working, The Stock Is Too Expensive (NYSE:STDN)

29 August 2026
Facebook X (Twitter) Instagram
Business Sunday, Aug 30
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Zomedica Corp. (ZOMDF) Discusses Five Pillars Framework for Clinical Value and Shareholder Returns in Veterinary Practice Transcript
News

Zomedica Corp. (ZOMDF) Discusses Five Pillars Framework for Clinical Value and Shareholder Returns in Veterinary Practice Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk27 June 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Zomedica Corp. (ZOMDF) Discusses Five Pillars Framework for Clinical Value and Shareholder Returns in Veterinary Practice Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

Unknown Executive

Welcome to Zomedica’s Fourth Friday at Four webinar series. Today, we’ll examine the 5 pillars framework, the operational foundation that guides every product, partnership and investment decision at Zomedica. We’ll walk through each pillar, the products behind them and what the framework means for veterinary practice performance and long-term recurring growth. Before we begin, I want to remind current and potential investors that we will be making various remarks about future expectations, plans and prospects that are considered forward-looking statements. There are risks that actual results may differ from these statements. We refer you to the safe harbor statement on screen or to the Risk Factors sections of our public filings, which can be found on our website under Investor filings, EDGAR and SEDAR+.

The statements are made as of today, June 26, 2026, and reflect our expectations as of today. Thank you for joining us for Zomedica’s investor webinar series. We’re excited to have you with us as we take a closer look at our company, our innovative product platforms and the passionate people driving our success. This series is designed to give you a deeper understanding of how we’re delivering value to veterinarians and to our shareholders. At Zomedica, our mission is to deliver innovative diagnostic and therapeutic technologies that empower veterinarians to focus on what they love most, enhancing pet care and improving pet parent satisfaction. Equally important, we help vets with what they need most, streamlining workflow, increasing cash flow and boosting practice profitability.

Now let’s hear from Larry Heaton, Zomedica’s Chief Executive Officer.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Microsoft Among 14 Dividend Growth Companies To Annual Dividend Increases In September

Fidelity Blue Chip Growth ETF Q2 2026 Commentary (FBCG)

Wasatch International Select Fund Q2 2026 Commentary (WAISX)

Janus Henderson Global Adaptive Capital Allocation Managed Account Q2 2026 Commentary

Standard Nuclear: The Business Is Working, The Stock Is Too Expensive (NYSE:STDN)

Jackson Hole’s Price Stability Message And The Threat To Equities

MUU: Up 2,510%, But Micron’s Next Move Could Change The Math (NASDAQ:MUU)

SBAR: 85% In A Money Market ETF, But That’s Not Where The 12% Yield Comes From (NYSEARCA:SBAR)

VCN:CA – A Strong Option For Canadian Equity Investors (TSX:VCN:CA)

Editors Picks

Fidelity Blue Chip Growth ETF Q2 2026 Commentary (FBCG)

30 August 2026

Wasatch International Select Fund Q2 2026 Commentary (WAISX)

30 August 2026

Janus Henderson Global Adaptive Capital Allocation Managed Account Q2 2026 Commentary

30 August 2026

Standard Nuclear: The Business Is Working, The Stock Is Too Expensive (NYSE:STDN)

29 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Jackson Hole’s Price Stability Message And The Threat To Equities

29 August 2026

MUU: Up 2,510%, But Micron’s Next Move Could Change The Math (NASDAQ:MUU)

29 August 2026

SBAR: 85% In A Money Market ETF, But That’s Not Where The 12% Yield Comes From (NYSEARCA:SBAR)

29 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.